$LRCX

ARCHER TIMOTHY sold $11.7M of LRCX

ARCHER TIMOTHY (President and CEO) sold 30,000 shares of LAM RESEARCH CORP (LRCX) at $390.01 ($11.70M total) on 2026-07-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · ARCHER TIMOTHY
Published Jul 6, 2026, 4:33 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 6, 2026, 4:38 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$LRCX
Neutral
medium confidence
Mentioned
$LRCX
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LRCXNeutralLow
01

Why it matters

Traders may briefly reassess sentiment around management confidence, but the 10b5-1 structure reduces the likelihood of a new negative catalyst.

02

Market read

A CEO open-market sale of $11.7M is disclosed, but pre-arranged 10b5-1 status suggests limited fundamental signal.

03

What to watch

The filing does not disclose reasons for the sale, and it provides no new company fundamentals (no guidance, contracts, or regulatory developments).

Relevance 6/10Novelty 5/10Timing: Filed 2026-07-06 for a sale executed 2026-07-02

Background

The article is an SEC Form 4 insider transaction disclosure for Lam Research (LRCX) by its President and CEO.

Company-level read

Ticker impact

$LRCXNeutralMedium confidence
Context

SEC Form 4 shows LRCX CEO Archer Timothy sold 30,000 shares in an open-market transaction worth $11.7M under a 10b5-1 plan.

Expected impact

Likely limited near-term price impact; any effect would be sentiment-driven rather than fundamental.

Evidence & confidence

The filing discloses transaction size and price ($390.01) plus 10b5-1 pre-arrangement, which typically reduces the likelihood of immediate negative fundamental information.

Market effects

Minimal; this is company-specific insider activity with no disclosed operational or guidance change.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect routine liquidity needs rather than bearish expectations.

Key entities

  • LRCX

    Lam Research Corp; subject of the Form 4 insider sale disclosure.

  • Archer Timothy

    President and CEO of LRCX who sold 30,000 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LRCXMed

The Memory Crunch Is Bigger Than Expected. 1 Top Stock to Buy on the Dip (Hint: Not Micron or Sandisk)

Lam Research (LRCX) is benefiting from a memory chip supply crunch, with revenue up 26% and earnings up 39% in fiscal 2026. The company expects 52% revenue growth and 71% earnings growth in the current quarter. Deloitte projects memory manufacturer capex to rise significantly, favoring Lam's semiconductor equipment sales. Analysts forecast 62% EPS growth for fiscal 2027, with potential for further upside.

$LRCXMedAI 8/10

Ministry approves Lam Research's NT$9.8 billion Taiwan investment

Taiwan's Ministry of Economic Affairs approved Lam Research's NT$9.835 billion (US$310 million) investment in its Taiwan subsidiary for semiconductor equipment R&D. Other approved investments include Zhen Ding Technology's NT$3 billion in Boardtek Electronics, Nuvoton's 15 billion yen in its Japan unit, and Foxconn's US$57.01 million in Mitsubishi Fuso Bus.